Erratum to ‘Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial’ Clin Mol Hepatol 2024;30:807-823
- Author:
Sun Young YIM
1
;
Sung Hwan LEE
;
Seung-Woo BAEK
;
Bohwa SOHN
;
Yun Seong JEONG
;
Sang-Hee KANG
;
Kena PARK
;
Hyewon PARK
;
Sunyoung S. LEE
;
Ahmed O. KASEB
;
Young Nyun PARK
;
Sun-Hee LEEM
;
Michael A. CURRAN
;
Ji Hoon KIM
;
Ju-Seog LEE
Author Information
- Publication Type:Erratum
- From:Clinical and Molecular Hepatology 2025;31(2):669-670
- CountryRepublic of Korea
- Language:English
